Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 155

1.

Incidence and mortality of nasopharyngeal carcinoma: interim analysis of a cluster randomized controlled screening trial (PRO-NPC-001) in southern China.

Ji MF, Sheng W, Cheng WM, Ng MH, Wu BH, Yu X, Wei KR, Li FG, Lian SF, Wang PP, Quan W, Deng L, Li XH, Liu XD, Xie YL, Huang SJ, Ge SX, Huang SL, Liang XJ, He SM, Huang HW, Xia SL, Ng PS, Chen HL, Xie SH, Liu Q, Hong MH, Ma J, Yuan Y, Xia NS, Zhang J, Cao SM.

Ann Oncol. 2019 Aug 2. pii: mdz231. doi: 10.1093/annonc/mdz231. [Epub ahead of print]

PMID:
31373615
2.

Structural and functional analyses of hepatitis B virus X protein BH3-like domain and Bcl-xL interaction.

Zhang TY, Chen HY, Cao JL, Xiong HL, Mo XB, Li TL, Kang XZ, Zhao JH, Yin B, Zhao X, Huang CH, Yuan Q, Xue D, Xia NS, Yuan YA.

Nat Commun. 2019 Jul 19;10(1):3192. doi: 10.1038/s41467-019-11173-1.

3.

The Optimal Concentration of Formaldehyde is Key to Stabilizing the Pre-Fusion Conformation of Respiratory Syncytial Virus Fusion Protein.

Zhang W, Zhang LJ, Zhan LT, Zhao M, Wu GH, Si JY, Chen L, Lin X, Sun YP, Lin M, Yu C, Fang MJ, Wang YB, Zheng ZZ, Xia NS.

Viruses. 2019 Jul 8;11(7). pii: E628. doi: 10.3390/v11070628.

4.

Robust in vitro assay for analyzing the neutralization activity of serum specimens against hepatitis B virus.

Zhang YL, Gao Y, Cao JL, Zhao JH, Zhang TY, Yang CL, Xiong HL, Wang YB, Ou SH, Cheng T, Chen CR, Yuan Q, Xia NS.

Emerg Microbes Infect. 2019;8(1):724-733. doi: 10.1080/22221751.2019.1619485.

5.

Baseline Level of Hepatitis B Core Antibody Predicts Spontaneous Hepatitis B e Antigen (HBeAg) Seroconversion in HBeAg-Positive Children With a Normal Alanine Aminotransferase Level.

Chen HS, Wu JF, Su TH, Chen HL, Hsu HY, Xia NS, Chen PJ, Chang MH.

Hepatology. 2019 May 23. doi: 10.1002/hep.30788. [Epub ahead of print]

PMID:
31121067
6.

Efficacy, safety, and immunogenicity of an Escherichia coli-produced bivalent human papillomavirus vaccine: An interim analysis of a randomized clinical trial.

Qiao YL, Wu T, Li RC, Hu YM, Wei LH, Li CG, Chen W, Huang SJ, Zhao FH, Li MQ, Pan QJ, Zhang X, Li Q, Hong Y, Zhao C, Zhang WH, Li YP, Chu K, Li M, Jiang YF, Li J, Zhao H, Lin ZJ, Cui XL, Liu WY, Li CH, Guo DP, Ke LD, Wu X, Tang J, Gao GQ, Li BY, Zhao B, Zheng FX, Dai CH, Guo M, Zhao J, Su YY, Wang JZ, Zhu FC, Li SW, Pan HR, Li YM, Zhang J, Xia NS.

J Natl Cancer Inst. 2019 May 11. pii: djz074. doi: 10.1093/jnci/djz074. [Epub ahead of print]

PMID:
31086947
7.

A unique B cell epitope-based particulate vaccine shows effective suppression of hepatitis B surface antigen in mice.

Zhang TY, Guo XR, Wu YT, Kang XZ, Zheng QB, Qi RY, Chen BB, Lan Y, Wei M, Wang SJ, Xiong HL, Cao JL, Zhang BH, Qiao XY, Huang XF, Wang YB, Fang MJ, Zhang YL, Cheng T, Chen YX, Zhao QJ, Li SW, Ge SX, Chen PJ, Zhang J, Yuan Q, Xia NS.

Gut. 2019 Mar 29. pii: gutjnl-2018-317725. doi: 10.1136/gutjnl-2018-317725. [Epub ahead of print]

8.

Application of Hepatitis E Virus-Related Markers on Samples from a Developing Country.

Wang SL, Gupta BP, Ji WF, Tang ZM, Wen GP, Adhikari A, Ying D, Zhang X, Liu C, Zheng ZZ, Xia NS.

Clin Lab. 2019 Mar 1;65(3). doi: 10.7754/Clin.Lab.2018.180708.

PMID:
30868849
9.

Structure and function analysis of the C. elegans aminophospholipid translocase TAT-1.

Chen YZ, Klöditz K, Lee ES, Nguyen DP, Yuan Q, Johnson J, Lee-Yow Y, Hall A, Mitani S, Xia NS, Fadeel B, Xue D.

J Cell Sci. 2019 Feb 28;132(5). pii: jcs227660. doi: 10.1242/jcs.227660.

10.

Rat Hepatitis E Virus as Cause of Persistent Hepatitis after Liver Transplant.

Sridhar S, Yip CCY, Wu S, Cai J, Zhang AJ, Leung KH, Chung TWH, Chan JFW, Chan WM, Teng JLL, Au-Yeung RKH, Cheng VCC, Chen H, Lau SKP, Woo PCY, Xia NS, Lo CM, Yuen KY.

Emerg Infect Dis. 2018 Dec;24(12):2241-2250. doi: 10.3201/eid2412.180937.

11.

[Establishment and evaluation of a triple-color human papillomavirus pseudovirion neutralization assay].

Wei SP, Fan F, Chen J, Liu XL, Yang YR, Wang ZP, Song S, Li ZH, Wei MX, Wang DN, Li SW, Xia NS.

Zhonghua Yu Fang Yi Xue Za Zhi. 2018 Oct 6;52(10):1039-1044. doi: 10.3760/cma.j.issn.0253-9624.2018.10.014. Chinese.

PMID:
30392324
12.

Association Between High Levels of Hepatitis B Core Antibody and Seroclearance of Hepatitis B e Antigen in Individuals With Chronic Hepatitis B Virus Infection.

Liu J, Hu HH, Chang CL, Jen CL, Lee MH, Lu SN, Wang LY, Yuan Q, Xia NS, Sugiyama M, Nishida N, Mizokami M, Chen CJ, Chen PJ, Yang HI.

Clin Gastroenterol Hepatol. 2019 Jun;17(7):1413-1415. doi: 10.1016/j.cgh.2018.09.037. Epub 2018 Sep 26.

PMID:
30267868
13.

An optimized high-throughput fluorescence plate reader-based RSV neutralization assay.

Sun YP, Zhang W, Zhao QJ, Cao JL, Zhang LJ, Xiang JY, Si JY, Lin X, Chen L, Zheng ZZ, Xia NS.

J Virol Methods. 2018 Oct;260:34-40. doi: 10.1016/j.jviromet.2018.07.004. Epub 2018 Jul 9.

PMID:
30003925
14.

Long-term HEV carriers without antibody seroconversion among eligible immunocompetent blood donors.

Wen GP, Chen CR, Song XY, Tang ZM, Ji WF, Wang SL, Zhang K, Zhang J, Ou SH, Zheng ZZ, Xia NS.

Emerg Microbes Infect. 2018 Jul 5;7(1):125. doi: 10.1038/s41426-018-0125-y.

15.

Level of Hepatitis B (HB) Core Antibody Associates With Seroclearance of HBV DNA and HB Surface Antigen in HB e Antigen-Seronegative Patients.

Hu HH, Liu J, Chang CL, Jen CL, Lee MH, Lu SN, Wang LY, Quan Y, Xia NS, Chen CJ, Chen PJ, Yang HI.

Clin Gastroenterol Hepatol. 2019 Jan;17(1):172-181.e1. doi: 10.1016/j.cgh.2018.04.064. Epub 2018 May 9.

PMID:
29753083
16.

Quantification of serum markers of hepatitis B (HBV) and Delta virus (HDV) infections in patients with chronic HDV infection.

Ricco G, Popa DC, Cavallone D, Iacob S, Salvati A, Tabacelia D, Oliveri F, Mascolo G, Bonino F, Yuan Q, Xia NS, Gheorghe L, Brunetto MR.

J Viral Hepat. 2018 Aug;25(8):911-919. doi: 10.1111/jvh.12895. Epub 2018 May 17.

PMID:
29577518
17.

The unique antibody suppresses HBV viremia and reduces hepatocarcinogenesis in HBV-transgenic mice.

Kang XZ, Guo XR, Chen BB, Zhang TY, Yuan Q, Chen PJ, Zhang J, Xia NS.

Hum Vaccin Immunother. 2018 Jul 3;14(7):1779-1781. doi: 10.1080/21645515.2018.1449553. Epub 2018 Apr 12. No abstract available.

18.

A novel noninvasive index for the prediction of moderate to severe fibrosis in chronic hepatitis B patients.

Li J, Mao RC, Li XL, Zheng JW, Qi X, Yuan Q, Zhang J, Zhang JM, Xia NS.

Dig Liver Dis. 2018 May;50(5):482-489. doi: 10.1016/j.dld.2017.12.028. Epub 2018 Jan 5.

PMID:
29396134
19.

[Clinical significance of quantitative level of hepatitis B core antibody].

Yuan Q, You H, Xia NS, Jia JD.

Zhonghua Gan Zang Bing Za Zhi. 2017 Dec 20;25(12):948-952. doi: 10.3760/cma.j.issn.1007-3418.2017.12.014. Chinese.

PMID:
29325300
20.

A cell-penetrating whole molecule antibody targeting intracellular HBx suppresses hepatitis B virus via TRIM21-dependent pathway.

Zhang JF, Xiong HL, Cao JL, Wang SJ, Guo XR, Lin BY, Zhang Y, Zhao JH, Wang YB, Zhang TY, Yuan Q, Zhang J, Xia NS.

Theranostics. 2018 Jan 1;8(2):549-562. doi: 10.7150/thno.20047. eCollection 2018.

21.

Structural basis of respiratory syncytial virus subtype-dependent neutralization by an antibody targeting the fusion glycoprotein.

Tian D, Battles MB, Moin SM, Chen M, Modjarrad K, Kumar A, Kanekiyo M, Graepel KW, Taher NM, Hotard AL, Moore ML, Zhao M, Zheng ZZ, Xia NS, McLellan JS, Graham BS.

Nat Commun. 2017 Nov 30;8(1):1877. doi: 10.1038/s41467-017-01858-w.

22.

Classification of human and zoonotic group hepatitis E virus (HEV) using antigen detection.

Wen GP, Tang ZM, Wang SL, Ji WF, Cai W, Zhang X, Huang SJ, Wu T, Zhang J, Zheng ZZ, Xia NS.

Appl Microbiol Biotechnol. 2017 Dec;101(23-24):8585-8594. doi: 10.1007/s00253-017-8526-8. Epub 2017 Oct 16.

PMID:
29038976
23.

Role of quantitative hepatitis B core antibody levels in predicting significant liver inflammation in chronic hepatitis B patients with normal or near-normal alanine aminotransferase levels.

Li J, Zhang TY, Song LW, Qi X, Yu XP, Li FH, Zhou P, Qin YL, Yang L, Zhao JH, Mao RC, Zhang YM, Wang JY, Yang FF, Zhu HX, Yang SS, Huang YX, Yuan Q, Zhang J, Zhang JM, Xia NS.

Hepatol Res. 2018 Feb;48(3):E133-E145. doi: 10.1111/hepr.12937. Epub 2017 Aug 29.

PMID:
28707778
24.

Discovery of a Prefusion Respiratory Syncytial Virus F-Specific Monoclonal Antibody That Provides Greater In Vivo Protection than the Murine Precursor of Palivizumab.

Zhao M, Zheng ZZ, Chen M, Modjarrad K, Zhang W, Zhan LT, Cao JL, Sun YP, McLellan JS, Graham BS, Xia NS.

J Virol. 2017 Jul 12;91(15). pii: e00176-17. doi: 10.1128/JVI.00176-17. Print 2017 Aug 1.

25.

Antibody-mediated immunotherapy against chronic hepatitis B virus infection.

Gao Y, Zhang TY, Yuan Q, Xia NS.

Hum Vaccin Immunother. 2017 Aug 3;13(8):1768-1773. doi: 10.1080/21645515.2017.1319021. Epub 2017 May 19.

26.

Epidemics and aetiology of hand, foot and mouth disease in Xiamen, China, from 2008 to 2015.

He SZ, Chen MY, Xu XR, Yan Q, Niu JJ, Wu WH, Su XS, Ge SX, Zhang SY, Xia NS.

Epidemiol Infect. 2017 Jul;145(9):1865-1874. doi: 10.1017/S0950268817000309. Epub 2017 Apr 3.

PMID:
28367766
27.

[The potential use of serum HBV RNA to guide the functional cure of chronic hepatitis B].

Lu FM, Wang J, Chen XM, Jiang JN, Zhang WH, Zhao JM, Ren H, Hou JL, Xia NS.

Zhonghua Gan Zang Bing Za Zhi. 2017 Feb 20;25(2):105-110. doi: 10.3760/cma.j.issn.1007-3418.2017.02.005. Chinese.

PMID:
28297795
28.

A novel toolbox for the in vitro assay of hepatitis D virus infection.

Zhao JH, Zhang YL, Zhang TY, Yuan LZ, Cheng T, Chen PJ, Yuan Q, Xia NS.

Sci Rep. 2017 Jan 12;7:40199. doi: 10.1038/srep40199.

29.

Baseline hepatitis B core antibody predicts treatment response in chronic hepatitis B patients receiving long-term entecavir.

Xu JH, Song LW, Li N, Wang S, Zeng Z, Si CW, Li J, Mao Q, Zhang DZ, Tang H, Sheng JF, Chen XY, Ning Q, Shi GF, Xie Q, Yuan Q, Yu YY, Xia NS.

J Viral Hepat. 2017 Feb;24(2):148-154. doi: 10.1111/jvh.12626. Epub 2016 Nov 28.

PMID:
27891715
30.

Persistence of antibodies acquired by natural hepatitis E virus infection and effects of vaccination.

Su YY, Huang SJ, Guo M, Zhao J, Yu H, He WG, Jiang HM, Wang YJ, Zhang XF, Cai JP, Yang CL, Wang ZZ, Zhu FC, Wu T, Zhang J, Xia NS.

Clin Microbiol Infect. 2017 May;23(5):336.e1-336.e4. doi: 10.1016/j.cmi.2016.10.029. Epub 2016 Nov 9.

31.

Pharmacological targeting of kinases MST1 and MST2 augments tissue repair and regeneration.

Fan F, He Z, Kong LL, Chen Q, Yuan Q, Zhang S, Ye J, Liu H, Sun X, Geng J, Yuan L, Hong L, Xiao C, Zhang W, Sun X, Li Y, Wang P, Huang L, Wu X, Ji Z, Wu Q, Xia NS, Gray NS, Chen L, Yun CH, Deng X, Zhou D.

Sci Transl Med. 2016 Aug 17;8(352):352ra108. doi: 10.1126/scitranslmed.aaf2304.

PMID:
27535619
32.

The Bama miniature swine is susceptible to experimental HEV infection.

Tang ZM, Wang SL, Ying D, Wen GP, Cai W, Zhang K, Ji WF, Yang M, Zheng ZZ, Xia NS.

Sci Rep. 2016 Aug 18;6:31813. doi: 10.1038/srep31813.

33.

A high-throughput neutralizing assay for antibodies and sera against hepatitis E virus.

Cai W, Tang ZM, Wen GP, Wang SL, Ji WF, Yang M, Ying D, Zheng ZZ, Xia NS.

Sci Rep. 2016 Apr 28;6:25141. doi: 10.1038/srep25141.

34.

Sleeping Beauty transposon-based system for rapid generation of HBV-replicating stable cell lines.

Wu Y, Zhang TY, Fang LL, Chen ZX, Song LW, Cao JL, Yang L, Yuan Q, Xia NS.

J Virol Methods. 2016 Aug;234:96-100. doi: 10.1016/j.jviromet.2016.04.010. Epub 2016 Apr 22.

PMID:
27091097
35.

Development of an HSV-1 neutralization test with a glycoprotein D specific antibody for measurement of neutralizing antibody titer in human sera.

Luo Y, Xiong D, Li HH, Qiu SP, Lin CL, Chen Q, Huang CH, Yuan Q, Zhang J, Xia NS.

Virol J. 2016 Mar 18;13:44. doi: 10.1186/s12985-016-0508-4.

36.

Evaluation of a novel chemiluminescent microplate enzyme immunoassay for hepatitis B surface antigen detection.

Yang L, Song LW, Fang LL, Wu Y, Ge SX, Li H, Yuan Q, Zhang J, Xia NS.

J Virol Methods. 2016 Feb;228:55-9. doi: 10.1016/j.jviromet.2015.11.013. Epub 2015 Nov 23.

PMID:
26615806
37.

Virus-mimetic nanovesicles as a versatile antigen-delivery system.

Zhang P, Chen Y, Zeng Y, Shen C, Li R, Guo Z, Li S, Zheng Q, Chu C, Wang Z, Zheng Z, Tian R, Ge S, Zhang X, Xia NS, Liu G, Chen X.

Proc Natl Acad Sci U S A. 2015 Nov 10;112(45):E6129-38. doi: 10.1073/pnas.1505799112. Epub 2015 Oct 26.

38.

Prolonged suppression of HBV in mice by a novel antibody that targets a unique epitope on hepatitis B surface antigen.

Zhang TY, Yuan Q, Zhao JH, Zhang YL, Yuan LZ, Lan Y, Lo YC, Sun CP, Wu CR, Zhang JF, Zhang Y, Cao JL, Guo XR, Liu X, Mo XB, Luo WX, Cheng T, Chen YX, Tao MH, Shih JW, Zhao QJ, Zhang J, Chen PJ, Yuan YA, Xia NS.

Gut. 2016 Apr;65(4):658-71. doi: 10.1136/gutjnl-2014-308964. Epub 2015 Sep 30.

PMID:
26423112
39.

Modeling the long-term antibody response of a hepatitis E vaccine.

Chen S, Zhou Z, Wei FX, Huang SJ, Tan Z, Fang Y, Zhu FC, Wu T, Zhang J, Xia NS.

Vaccine. 2015 Aug 7;33(33):4124-9. doi: 10.1016/j.vaccine.2015.06.050. Epub 2015 Jun 28.

PMID:
26126668
40.

Total Hepatitis B Core Antigen Antibody, a Quantitative Non-Invasive Marker of Hepatitis B Virus Induced Liver Disease.

Yuan Q, Song LW, Cavallone D, Moriconi F, Cherubini B, Colombatto P, Oliveri F, Coco BA, Ricco G, Bonino F, Shih JW, Xia NS, Brunetto MR.

PLoS One. 2015 Jun 26;10(6):e0130209. doi: 10.1371/journal.pone.0130209. eCollection 2015.

41.

Immunogenicity and safety of an E. coli-produced bivalent human papillomavirus (type 16 and 18) vaccine: A randomized controlled phase 2 clinical trial.

Wu T, Hu YM, Li J, Chu K, Huang SJ, Zhao H, Wang ZZ, Yang CL, Jiang HM, Wang YJ, Lin ZJ, Pan HR, Sheng W, Wei FX, Li SW, Wang Y, Zhu FC, Li CG, Zhang J, Xia NS.

Vaccine. 2015 Jul 31;33(32):3940-6. doi: 10.1016/j.vaccine.2015.06.052. Epub 2015 Jun 19.

PMID:
26100924
42.

A Comprehensive Study of Neutralizing Antigenic Sites on the Hepatitis E Virus (HEV) Capsid by Constructing, Clustering, and Characterizing a Tool Box.

Zhao M, Li XJ, Tang ZM, Yang F, Wang SL, Cai W, Zhang K, Xia NS, Zheng ZZ.

J Biol Chem. 2015 Aug 7;290(32):19910-22. doi: 10.1074/jbc.M115.649764. Epub 2015 Jun 17.

43.

A novel linear neutralizing epitope of hepatitis E virus.

Tang ZM, Tang M, Zhao M, Wen GP, Yang F, Cai W, Wang SL, Zheng ZZ, Xia NS.

Vaccine. 2015 Jul 9;33(30):3504-11. doi: 10.1016/j.vaccine.2015.05.065. Epub 2015 Jun 4.

PMID:
26051517
44.

Long-term efficacy of a hepatitis E vaccine.

Zhang J, Shih JW, Xia NS.

N Engl J Med. 2015 Jun 4;372(23):2265-6. doi: 10.1056/NEJMc1504302. No abstract available.

PMID:
26039604
45.

Rapid fluorescent lateral-flow immunoassay for hepatitis B virus genotyping.

Song LW, Wang YB, Fang LL, Wu Y, Yang L, Chen JY, Ge SX, Zhang J, Xiong YZ, Deng XM, Min XP, Zhang J, Chen PJ, Yuan Q, Xia NS.

Anal Chem. 2015;87(10):5173-80. doi: 10.1021/ac504832c. Epub 2015 May 5.

PMID:
25892477
46.

Long-term efficacy of a hepatitis E vaccine.

Zhang J, Zhang XF, Huang SJ, Wu T, Hu YM, Wang ZZ, Wang H, Jiang HM, Wang YJ, Yan Q, Guo M, Liu XH, Li JX, Yang CL, Tang Q, Jiang RJ, Pan HR, Li YM, Shih JW, Ng MH, Zhu FC, Xia NS.

N Engl J Med. 2015 Mar 5;372(10):914-22. doi: 10.1056/NEJMoa1406011. Erratum in: N Engl J Med. 2015 Apr 9;372(15):1478.

47.

The development of a recombinant hepatitis E vaccine HEV 239.

Li SW, Zhao Q, Wu T, Chen S, Zhang J, Xia NS.

Hum Vaccin Immunother. 2015;11(4):908-14. doi: 10.1080/21645515.2015.1008870. Review.

48.

Quantitative hepatitis B core antibody levels in the natural history of hepatitis B virus infection.

Song LW, Liu PG, Liu CJ, Zhang TY, Cheng XD, Wu HL, Yang HC, Hao XK, Yuan Q, Zhang J, Kao JH, Chen DS, Chen PJ, Xia NS.

Clin Microbiol Infect. 2015 Feb;21(2):197-203. doi: 10.1016/j.cmi.2014.10.002. Epub 2014 Oct 29.

49.

A lysine-rich motif in the phosphatidylserine receptor PSR-1 mediates recognition and removal of apoptotic cells.

Yang H, Chen YZ, Zhang Y, Wang X, Zhao X, Godfroy JI 3rd, Liang Q, Zhang M, Zhang T, Yuan Q, Ann Royal M, Driscoll M, Xia NS, Yin H, Xue D.

Nat Commun. 2015 Jan 7;6:5717. doi: 10.1038/ncomms6717.

50.

Quantitative hepatitis B core antibody level is a new predictor for treatment response in HBeAg-positive chronic hepatitis B patients receiving peginterferon.

Hou FQ, Song LW, Yuan Q, Fang LL, Ge SX, Zhang J, Sheng JF, Xie DY, Shang J, Wu SH, Sun YT, Wei SF, Wang MR, Wan MB, Jia JD, Luo GH, Tang H, Li SC, Niu JQ, Zhou WD, Sun L, Xia NS, Wang GQ.

Theranostics. 2015 Jan 1;5(3):218-26. doi: 10.7150/thno.10636. eCollection 2015.

Supplemental Content

Support Center